SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-087631
Filing Date
2023-08-04
Accepted
2023-08-04 10:58:21
Documents
16
Period of Report
2023-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322902d2_8k.htm   iXBRL 8-K 33694
2 EXHIBIT 10.1 tm2322902d2_ex10-1.htm EX-10.1 28715
3 EXHIBIT 99.1 tm2322902d2_ex99-1.htm EX-99.1 93056
7 GRAPHIC tm2322902d1_ex99-1img001.jpg GRAPHIC 8041
8 GRAPHIC tm2322902d2_ex10-1img001.jpg GRAPHIC 8041
  Complete submission text file 0001104659-23-087631.txt   376817

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fencf-20230803.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20230803_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20230803_pre.xml EX-101.PRE 22358
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2322902d2_8k_htm.xml XML 3327
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 231142669
SIC: 2836 Biological Products, (No Diagnostic Substances)